OK Science and Technology Co., Ltd.
SZSE:001223.SZ
65 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 199.196 | 111.954 | 108.447 | 88.053 | 124.341 | 40.713 | 116.011 | 80.981 | 94.596 | 84.465 | 193.337 | 113.144 | 125.957 | 136.122 | 212.542 | 98.122 |
| Cost of Revenue
| 125.992 | 89.563 | 72.741 | 60.087 | 80.03 | 43.86 | 73.432 | 46.297 | 63.711 | 57.99 | 98.21 | 53.145 | 65.779 | 74.27 | 106.877 | 45.323 |
| Gross Profit
| 73.203 | 22.391 | 35.707 | 27.966 | 44.312 | -3.147 | 42.579 | 34.684 | 30.885 | 26.475 | 95.127 | 59.999 | 60.178 | 61.852 | 105.665 | 52.799 |
| Gross Profit Ratio
| 0.367 | 0.2 | 0.329 | 0.318 | 0.356 | -0.077 | 0.367 | 0.428 | 0.326 | 0.313 | 0.492 | 0.53 | 0.478 | 0.454 | 0.497 | 0.538 |
| Reseach & Development Expenses
| 6.68 | 14.109 | 5.35 | 6.833 | 6.554 | 10.397 | 3.711 | 4.214 | 4.908 | 4.074 | 6.863 | 5.712 | 5.546 | 9.366 | 5.717 | 3.587 |
| General & Administrative Expenses
| 12.283 | -20.567 | 27.784 | -7.753 | 11.992 | -16.454 | 20.898 | -3.693 | 7.943 | 10.536 | -8.577 | -3.437 | 6.558 | -5.736 | 4.951 | 3.852 |
| Selling & Marketing Expenses
| 5.173 | -3.917 | 7.855 | 4.905 | 4.687 | 3.322 | 4.269 | 6.158 | 3.324 | 4.516 | 5.345 | 4.856 | 3.565 | 3.907 | 3.824 | 3.238 |
| SG&A
| 17.456 | -24.484 | 19.161 | 11.288 | 24.497 | -13.132 | 25.167 | 2.465 | 11.267 | 25.895 | -3.233 | 1.419 | 10.123 | -1.828 | 8.775 | 7.09 |
| Other Expenses
| 1.325 | 73.914 | -2.487 | 1.012 | 3.162 | 11.026 | -0.017 | -1.031 | -0.081 | -17.667 | -0.131 | -0.011 | -0.033 | -0.06 | 0.004 | -0.048 |
| Operating Expenses
| 25.461 | 63.54 | 22.135 | 17.109 | 27.889 | 1.529 | -31.213 | 13.458 | 4.009 | 12.302 | -6.599 | 12.081 | 7.799 | 7.589 | 4.994 | 6.964 |
| Operating Income
| 47.742 | -41.149 | 13.684 | 10.857 | 16.423 | -7.256 | 68.773 | 21.961 | 34.618 | 14.173 | 100.137 | 48.366 | 50.103 | 46.914 | 102.769 | 46.034 |
| Operating Income Ratio
| 0.24 | -0.368 | 0.126 | 0.123 | 0.132 | -0.178 | 0.593 | 0.271 | 0.366 | 0.168 | 0.518 | 0.427 | 0.398 | 0.345 | 0.484 | 0.469 |
| Total Other Income Expenses Net
| -0.062 | 7.895 | 0.05 | 0.86 | 0.001 | 11.026 | -0.017 | -1.031 | -0.081 | 1.895 | -0.131 | -0.011 | -0.033 | -0.06 | 0.004 | -0.048 |
| Income Before Tax
| 47.68 | -33.253 | 13.734 | 15.889 | 35.892 | 3.77 | 68.756 | 20.93 | 34.537 | 16.068 | 100.005 | 48.355 | 50.071 | 46.854 | 102.773 | 45.986 |
| Income Before Tax Ratio
| 0.239 | -0.297 | 0.127 | 0.18 | 0.289 | 0.093 | 0.593 | 0.258 | 0.365 | 0.19 | 0.517 | 0.427 | 0.398 | 0.344 | 0.484 | 0.469 |
| Income Tax Expense
| 5.944 | -10.537 | 0.397 | 2.865 | 3.778 | -2.8 | 10.214 | 1.569 | 5.078 | 1.988 | 15.058 | 5.857 | 8.38 | 4.739 | 14.09 | 7.427 |
| Net Income
| 40.534 | -24.016 | 13.337 | 12.697 | 32.27 | 6.57 | 58.542 | 19.361 | 29.46 | 14.08 | 84.947 | 42.498 | 41.691 | 42.115 | 88.683 | 38.56 |
| Net Income Ratio
| 0.203 | -0.215 | 0.123 | 0.144 | 0.26 | 0.161 | 0.505 | 0.239 | 0.311 | 0.167 | 0.439 | 0.376 | 0.331 | 0.309 | 0.417 | 0.393 |
| EPS
| 0.61 | -0.36 | 0.2 | 0.19 | 0.48 | 0.099 | 0.88 | 0.29 | 0.44 | 0.28 | 1.7 | 0.64 | 0.83 | 0.89 | 1.77 | 0.77 |
| EPS Diluted
| 0.61 | -0.36 | 0.2 | 0.19 | 0.48 | 0.099 | 0.88 | 0.29 | 0.44 | 0.28 | 1.7 | 0.64 | 0.83 | 0.89 | 1.77 | 0.77 |
| EBITDA
| 48.247 | -29.247 | 23.112 | 24.369 | 36.066 | 9.787 | 74.646 | 20.951 | 34.643 | -9.788 | 104.939 | 53.086 | 55.125 | 50.547 | 103.25 | 48.845 |
| EBITDA Ratio
| 0.242 | -0.261 | 0.213 | 0.277 | 0.29 | 0.24 | 0.643 | 0.259 | 0.366 | -0.116 | 0.543 | 0.469 | 0.438 | 0.371 | 0.486 | 0.498 |